Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b/2 Study of AVUTOMETINIB and Cetuximab in Participants With Advanced KRAS Mutated Colorectal Cancer

NCT05200442 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT05200442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05200442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b/2 Study of AVUTOMETINIB and Cetuximab in Participants With Advanced KRAS Mutated Colorectal Cancer
Lead sponsor
University of Chicago
Phase
Phase 1/2
Overall status
Suspended
Start date
August 22, 2022
Completion date
May 1, 2027
Enrollment
53 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced colorectal adenocarcinoma, advanced colorectal carcinoma, colorectal adenocarcinoma, colorectal cancer, colorectal cancer metastatic